4-[2-[[5-METHYL-1-(2-NAPHTALENYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINE SALTS

600310 The present disclosure relates to 4-[-2-[[5-methyl-1 -(2-naphthalenyl)-1 H-pyrazol-3- yl]oxy]ethyl]morpholine salts, specifically to the hydrochloride, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of sigma receptor associated diseases.

Saved in:
Bibliographic Details
Main Authors SOLA - CARANDELL, LLUIS, CUBERES-ALTISENT, MARIA ROSA, GARCIA - COUCEIRO, URKO
Format Patent
LanguageEnglish
Published 30.08.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 600310 The present disclosure relates to 4-[-2-[[5-methyl-1 -(2-naphthalenyl)-1 H-pyrazol-3- yl]oxy]ethyl]morpholine salts, specifically to the hydrochloride, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of sigma receptor associated diseases.
AbstractList 600310 The present disclosure relates to 4-[-2-[[5-methyl-1 -(2-naphthalenyl)-1 H-pyrazol-3- yl]oxy]ethyl]morpholine salts, specifically to the hydrochloride, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of sigma receptor associated diseases.
Author SOLA - CARANDELL, LLUIS
CUBERES-ALTISENT, MARIA ROSA
GARCIA - COUCEIRO, URKO
Author_xml – fullname: SOLA - CARANDELL, LLUIS
– fullname: CUBERES-ALTISENT, MARIA ROSA
– fullname: GARCIA - COUCEIRO, URKO
BookMark eNrjYmDJy89L5WTwMdGNNtKNjjbV9XUN8Yj00TXU1TDS9XMM8Ahx9HH1i_TR1DX00A2IDHKM8vfRNdaN9In1j4iMBauN9fUPCvDw9_H0c1UIdvQJCeZhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfF-UWYGBsaGBo7GBBUAAM7HLsU
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID NZ600310A
GroupedDBID EVB
ID FETCH-epo_espacenet_NZ600310A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:52:52 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_NZ600310A3
Notes Application Number: NZ20100600310
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130830&DB=EPODOC&CC=NZ&NR=600310A
ParticipantIDs epo_espacenet_NZ600310A
PublicationCentury 2000
PublicationDate 20130830
PublicationDateYYYYMMDD 2013-08-30
PublicationDate_xml – month: 08
  year: 2013
  text: 20130830
  day: 30
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies LABORATORIOS DEL DR. ESTEVE S.A
RelatedCompanies_xml – name: LABORATORIOS DEL DR. ESTEVE S.A
Score 2.900289
Snippet 600310 The present disclosure relates to 4-[-2-[[5-methyl-1 -(2-naphthalenyl)-1 H-pyrazol-3- yl]oxy]ethyl]morpholine salts, specifically to the hydrochloride,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 4-[2-[[5-METHYL-1-(2-NAPHTALENYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINE SALTS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130830&DB=EPODOC&locale=&CC=NZ&NR=600310A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT4MwEL_MadQ3nd8fyx4M0YdGBAa8EMOABU0pZEMztpCFMjS-sMVh_Pe9NUx92VvTNpfLJXe__treHcCNXnCENQ3ZSWboSFA0nXA104iq50p3hviSFyuiGDDdf9GeR91RA97XuTCiTui3KI6IHpWjv1ciXi_-LrFc8bdyec8_cGr-2I8tV6rZMQZkU5Ult2d5UeiGjuQ4FhtLbGDpogamvQXbeIY2BGN77a1SUhb_8aR_ADsRiiqrQ2gUZQv2nHXbtRbsBvVrNw5rx1seAdXIRCGTSZcEXuwnFCnZrUKYHfmxTT2W0Dvy4JMoGdjjkBKVJDQNR0kq9qZBOIj8kD4xrzO0aTw8hnbfix2foFrTXwNM2bhWXz2BZjkvizPomEqWIRXh3DBnGpezbAXspvGWc0U2i5l8DqcbhFxsXLmEfUV0ezCJKl9Bs_r8Kq4RcyveFvb6ASF2gC0
link.rule.ids 230,309,783,888,25577,76883
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT4MwEL_MaZxvOr8_5h4M0YdGBMZ4IYYBC2opZKIZW5aFMjS-sMVh_Pc9Gqa-7K1pm8vlkrtff-3dFeBKzzjCmobsJOnqSFA0nXA10Yiqp0pnhviSZiVR9JnuvWiPw86wBu-rWhjRJ_RbNEdEj0rR3wsRrxd_l1iOyK1c3vIPnJrf9yPTkSp2jAHZUGXJ6ZluGDiBLdm2yUYSG5i66IFpbcAmnq8NwZNee2VJyuI_nvR3YStEUXmxB7Usb0LDXn271oRtv3rtxmHleMt9oBoZK2Q87hDfjbyYIiW7VgizQi-yqMtiekPuPBLGA2sUUKKSmE6CYTwReyd-MAi9gD4wt_1s0ej5AFp9N7I9gmpNfw0wZaNKffUQ6vk8z46hbShJglSE864x07icJCWwG923lCuykc3kEzhaI-R07colNLzIp1NU6OkMdhTx80OZ23cO9eLzK7tA_C14S9juB0vmgxg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=4-%5B2-%5B%5B5-METHYL-1-%282-NAPHTALENYL%29-1H-PYRAZOL-3-YL%5DOXY%5DETHYL%5DMORPHOLINE+SALTS&rft.inventor=SOLA+-+CARANDELL%2C+LLUIS&rft.inventor=CUBERES-ALTISENT%2C+MARIA+ROSA&rft.inventor=GARCIA+-+COUCEIRO%2C+URKO&rft.date=2013-08-30&rft.externalDBID=A&rft.externalDocID=NZ600310A